
Please try another search
Genovate Biotechnology Co., Ltd. engages in the research, development, manufacture, production, and sale of products to prevent and treat diseases caused by viruses and bacteria in Taiwan. It provides drugs, APIs, intermediates, and release agents for the treatment of cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune diseases; and controlled-release dosage forms of Western medicine, as well as cosmetics. The company was founded in 1982 and is based in Hsinchu City, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Zheng Chen | 72 | - | Chairman & CSO |
Chi-Ying Huang | - | 2023 | Representative Director |
Chia-Chen Chu | - | - | General Manager & Director |
Shih-Jen Lee | - | - | Independent Director |
Hsiu-hui Chen | - | 2023 | Representative Director |
Chin-Ming Chang | - | 2023 | Independent Director |
Ke Yi Liu | - | - | Independent Director |
Qi Neng Zhang | - | - | Supervisor |
Li Hui Zhu | - | 2006 | Supervisor |
Lau-Shou Su | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review